上市公司控制权变更
Search documents
奥联电子临时停牌后官宣,筹划控制权变更!
Xin Lang Cai Jing· 2025-12-22 13:00
上海明伦律师事务所王智斌律师告诉《证券日报》记者,上市公司的控制权变更通常有五种情形:协议 转让、要约收购、司法处置、表决权委托、上市公司重组。其中,协议转让最为常见,虽然控制权的变 更是多样性的,但核心都是控制权的实质性转移。在二级市场,上市公司控制权的变更,容易引发投资 者的关注,投资者要关注合规性,以及控制权变更后的主营业务持续性。上市公司筹划控制权变更的过 程中,必须及时、准确、完整地披露相关信息,避免内幕交易、市场操纵等违法行为。 "上市公司控制权变更之事要辩证来看,一方面,部分上市公司面临着业绩压力,转让控制权,通过引 入'新鲜血液'尝试转型,也是一种选择;另一方面,借助不同背景的股东,助力企业实现产业链整合、 战略投资或资源优化配置,也可以让资本市场的资源更高效、合理地配置。"福建华策品牌定位咨询创 始人詹军豪在接受《证券日报》记者采访时表示。 炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 这家公司临时停牌后官宣,筹划控制权变更! 来源:证券日报之声 本报记者 桂小笋 12月22日早间,南京奥联汽车电子电器股份有限公司(以下简称"奥联电子(维权)")发布临时停牌的 公 ...
这家公司临时停牌后官宣,筹划控制权变更!
Zheng Quan Ri Bao Wang· 2025-12-22 12:45
12月22日早间,南京奥联汽车电子电器股份有限公司(以下简称"奥联电子(300585)")发布临时停牌 的公告,拟披露重大事项。至12月22日晚间,奥联电子披露了公司临时停牌的原因:12月19日收到控股 股东广西瑞盈资产管理有限公司(以下简称"瑞盈资产")的通知,获悉瑞盈资产正在筹划有关协议转让 所持有的公司部分股权等事宜,该事项可能导致公司控股股东、实际控制人发生变更。 目前,各方主体正在就具体交易方案、协议等相关事项进行论证和磋商。在公告中,奥联电子提及,经 公司向深圳证券交易所申请,公司股票自12月22日开市起停牌,预计停牌时间不超过2个交易日。 不过,控制权的变更能否让相关上市公司"面貌一新"?詹军豪认为,仍要看后续实际赋能效果,"要看 能否在产业协同、'强链补链'上有实质性进展。" 其他信息来看,奥联电子主营业务属于汽车零部件制造,产品涉及动力电子控制、车身电子控制及新能 源系统控制等领域。今年11月份,公司刚完成董事会换届事项。 上海明伦律师事务所王智斌律师告诉《证券日报》记者,上市公司的控制权变更通常有五种情形:协议 转让、要约收购、司法处置、表决权委托、上市公司重组。其中,协议转让最为常见,虽 ...
河南太龙药业股份有限公司
Shang Hai Zheng Quan Bao· 2025-12-08 17:54
"1、不会越权干预公司经营管理活动,不会侵占公司利益; 2、自本承诺出具日至公司本次向特定对象发行股票实施完毕前,若中国证监会及上海证券交易所做出 关于填补回报措施及其承诺的其他新的监管规定的,且上述承诺不能满足中国证监会及上海证券交易所 该等规定时,本单位承诺届时将按照中国证监会及上海证券交易所的最新规定出具补充承诺; 3、切实履行公司制定的有关填补回报措施以及本单位对此作出的任何有关填补回报措施的承诺,若本 单位违反该等承诺并给公司或者投资者造成损失的,本单位愿意依法承担对公司或者投资者的补偿责 任。" 登录新浪财经APP 搜索【信披】查看更多考评等级 特此公告。 河南太龙药业股份有限公司董事会 2025年12月9日 证券代码:600222 证券简称:太龙药业 公告编号:2025-064 河南太龙药业股份有限公司 关于股东签署《股份转让协议》《一致行动协议》 及公司签署《附条件生效的股份认购协议》 暨控股股东、实际控制人拟发生变更的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示: ● 控股股东或实 ...
思创医惠(300078.SZ):股东解除《股份转让协议》暨实际控制人、控股股东终止变更
Ge Long Hui A P P· 2025-11-17 13:11
格隆汇11月17日丨思创医惠(300078.SZ)公布,公司第一大股东路楠先生与苍南县工业建设投资有限公 司(简称"苍南建投"、"乙方"或"受让方")于2025年4月26日签署了《股份转让协议》,约定路楠先生 拟通过协议转让的方式将其所直接持有的本公司共计62,739,500股的股份(占公司总股本的5.61%)转 让给苍南建投,转让完成后路楠先生不直接持有本公司股份,通过其一致行动人杭州博泰投资管理有限 公司(简称"杭州博泰")间接持有本公司6,006,776股的股份(占公司总股本的0.54%)。本次股份转让 过户完成后,苍南建投将持有本公司股份62,739,500股,占公司总股本的5.61%,苍南县思加物联智能 合伙企业(有限合伙)(简称"思加物联"),持有本公司股份63,890,185股,占公司总股本的5.72%,苍 南建投与思加物联将合计持有本公司股份126,629,685股,占公司总股本的11.33%。根据苍南建投与思 加物联的工商登记信息及股权结构,苍南建投与思加物联均为受苍南县财政局控制的企业。因此,本次 股份转让过户完成后,公司第一大股东将由路楠先生及其一致行动人杭州博泰变更为思加物联,公司将 ...
皓宸医疗:汇垠澳丰无实际控制人 上市公司亦无实际控制人
Guo Ji Jin Rong Bao· 2025-11-14 14:26
Core Viewpoint - The announcement from Haocen Medical indicates a change in control due to the termination of a cooperation agreement between Huyin Aofeng and Beijing Shoutuo Ronghui, resulting in no actual controller for the listed company [1] Group 1 - Huyin Aofeng, through Huyin Rifeng, indirectly controls 23.81% of the voting rights of the listed company [1] - Huyin Aofeng's shareholders have balanced shareholding ratios and no concerted action arrangements, leading to the absence of an actual controller [1] - The change in equity will not adversely affect the normal production and operation of the company [1]
济南市历城区财政局入主不足三年后即退出遭问询 中达安回复
2 1 Shi Ji Jing Ji Bao Dao· 2025-11-04 02:35
Group 1 - The Shenzhen Stock Exchange has inquired about the recent change in control of Zhongda An (300635.SZ), focusing on why the Jinan Licheng District Finance Bureau plans to exit after less than three years of ownership [1] - The Licheng District Finance Bureau confirmed it will actively relinquish control through a targeted capital increase, having initially acquired Zhongda An to leverage its engineering supervision business with local urban development [1] - The market environment has changed significantly post-control transfer, with a downturn in the real estate sector leading to reduced demand for traditional supervision services and ongoing performance pressure [1] Group 2 - The Licheng District Finance Bureau's decision to not participate in the capital increase and relinquish control is deemed reasonable, as it aims to redirect resources towards attracting industry and its own transformation rather than additional investment in the listed company [1] - A new controlling shareholder with a background in the renewable energy industry is being introduced, aligning with the current regional industrial direction and the transformation needs of the listed company [1] - The introduction of a strategic investor is expected to optimize the equity structure of the listed company and enhance its long-term development capabilities [1] Group 3 - The Licheng District State-owned Assets is actively introducing Xiamen Jianxi, controlled by Wang Li, whose Xinyi Group focuses on the renewable energy and pharmaceutical industries, aligning well with Jinan's key development areas such as "intelligent manufacturing and new energy equipment" [2] - Xinyi Group's subsidiary, Jinmao Smart Transportation Technology Co., Ltd., has established a presence in Jinan, planning to invest in a production base for vehicle battery boxes and equipment for battery swapping stations, including battery swapping robots [2]
002397被责令改正,三高管收警示函
Shang Hai Zheng Quan Bao· 2025-10-20 23:07
Core Viewpoint - Mengjie Co., Ltd. has received regulatory measures from Hunan Securities Regulatory Bureau due to violations related to financial management and disclosure practices, which include improper revenue recognition and financial assistance to third parties [1][3][4]. Summary by Sections Regulatory Actions - Hunan Securities Regulatory Bureau has issued a decision to Mengjie Co., Ltd. to rectify its practices and has provided warning letters to key executives including Chairman Jiang Tianwu, General Manager Tu Yunhua, and CFO Li Yunlong [1][4]. - The company is required to complete rectification within three months and submit a written report within 15 working days after completion [4]. Violations Identified - Two major violations were identified: 1. Improper revenue and cost recognition for direct sales from 2022 to 2024, including issues with sales rebates and employee compensation [3][4]. 2. Financial assistance provided to a third party, with outstanding loans amounting to 63.3763 million yuan as of September 30, 2023, and a failure to pursue repayment [4]. Shareholding Changes - As of August 11, 2025, Mengjie Co., Ltd. will have no controlling shareholder or actual controller, with Jiang Tianwu becoming the largest shareholder with 13.52% voting rights [5][7]. - The previous agreement with Changsha Jinsen, which allowed for shared voting rights, will be terminated, leading to a more dispersed shareholding structure [6][7]. Recent Share Transfer Agreements - Shareholder Wu Jing has signed a supplementary agreement to transfer 10.65% of shares to Qingyun Digital Technology, with a total transaction value of approximately 230 million yuan [9][10]. - The transfer will not change the control of the company, and the transaction is subject to compliance review by the Shenzhen Stock Exchange [10].
退出大恒科技,徐翔家族渐别A股!8位买家背景公开
Bei Jing Shang Bao· 2025-10-12 14:25
Core Viewpoint - The judicial auction of approximately 130 million unrestricted circulating shares held by Zheng Suzhen, the controlling shareholder of Daheng Technology, marks the end of the Xu Xiang family's involvement in the A-share market, leading to the company becoming "ownerless" [1][3][12]. Group 1: Company Ownership Changes - Daheng Technology announced that Zheng Suzhen has completely exited the company, resulting in a change of control to a state with no controlling shareholder or actual controller [3][4]. - The auction was completed with a total transaction price of approximately 1.712 billion yuan, with the new shareholders including seven individuals and one corporate entity, China New Era [1][3]. Group 2: Background of New Shareholders - Li Rongrong has become the largest shareholder of Daheng Technology, holding 40.46 million shares, which is 9.26% of the total share capital, with funding sources including 242 million yuan of personal funds and 120 million yuan of self-raised funds [3][4]. - China New Era, the only corporate buyer, provided approximately 237 million yuan for the auction, all from its own funds [4][7]. Group 3: Financial Implications and Market Reactions - The financing costs for some new shareholders are notably high, with borrowing rates reaching up to 12%, raising concerns about the financial stability of the new ownership structure [5][6]. - Analysts suggest that the absence of a controlling shareholder may lead to instability in control and potential shareholder disputes, necessitating stronger governance mechanisms [5][6]. Group 4: Company Performance and Future Plans - Daheng Technology has experienced a decline in net profit for three consecutive years, with a reported loss of 2.7405 million yuan in the first half of the current year [8]. - The company plans to establish a wholly-owned subsidiary in Shanghai with an investment of 600 million yuan to engage in semiconductor-related auxiliary equipment business, aiming to enhance its strategic development [8].
三家上市公司同日停牌筹划“易主”两药企陷业绩泥潭
Mei Ri Jing Ji Xin Wen· 2025-09-29 14:03
Core Viewpoint - Three listed companies, Duori Pharmaceutical, Asia-Pacific Pharmaceutical, and Zhonghuan Environmental Protection, announced on the same day that they are planning changes in control, which may lead to changes in their controlling shareholders and actual controllers [1] Group 1: Duori Pharmaceutical - Duori Pharmaceutical's major shareholder, Tibet Jiakang Times Technology Development Co., is planning a change in control, which may lead to a change in the company's controlling shareholder and actual controller [2] - The company has experienced continuous revenue decline from 2022 to 2024, which may be a reason for the planned change in control [2] - Duori Pharmaceutical's revenue for the first half of 2025 was 107 million yuan, a year-on-year decline of 29.13%, with a net loss of 42.5 million yuan, compared to a loss of 3.27 million yuan in the same period last year [3] Group 2: Asia-Pacific Pharmaceutical - Asia-Pacific Pharmaceutical's major shareholder, Ningbo Fubang Holdings Group, is also planning a change in control, with specific transaction plans and agreements still under discussion [4] - The company has faced continuous revenue decline, with a net profit of -48.86 million yuan for the first half of 2025, a year-on-year decrease of 524.31% [5] - Asia-Pacific Pharmaceutical's revenue for the first half of 2025 was 152 million yuan, a year-on-year decrease of 31.48%, attributed to centralized procurement and intensified market competition [5]
亏损泥潭难自拔,实控人6年终退场,亿晶光电陷“无主”状态
3 6 Ke· 2025-09-28 03:29
Core Viewpoint - The exit of Weizhi Energy marks a significant turning point for Yijing Photovoltaic, transitioning the company into a "no owner" status after a judicial transfer of shares, leading to a change in actual control [1][10]. Group 1: Share Transfer and Control Change - Weizhi Energy's shares, approximately 150 million, were publicly auctioned by the Futian Court, resulting in a reduction of its holdings from 12.67% to 8.45% [1][2]. - The shares were divided into three batches, each sold to different buyers at prices around 3.05 to 3.08 yuan per share, totaling approximately 1.5 million yuan for each batch [2][3]. - The auction and subsequent transfer of shares signify a forced exit for Weizhi Energy due to financial pressures from its associated real estate company [4]. Group 2: Financial Performance and Challenges - Yijing Photovoltaic experienced significant financial struggles, with a debt ratio nearing 95% and a history of substantial losses since 2012, exacerbated by industry downturns and operational challenges [4][11]. - In 2022, the company reported a revenue of 9.876 billion yuan and a net profit of approximately 127 million yuan, but faced a sharp decline in 2023, with revenue and net profit both decreasing [5][7]. - Projections for 2024 indicate a revenue drop of 57.07% and a loss of approximately 2.09 billion yuan, with no profitable quarters anticipated [6][7]. Group 3: Governance and Future Outlook - The absence of a controlling shareholder raises governance concerns, as decision-making will rely on board collaboration, which could lead to inefficiencies [8][10]. - The company is under scrutiny from the Shanghai Stock Exchange regarding the potential risks associated with having no actual controller and the implications for corporate governance [9][10]. - Despite the challenges, the removal of Weizhi Energy may provide Yijing Photovoltaic an opportunity to shed historical burdens and potentially improve its operational strategies moving forward [8][12].